Evan Chen, MD, is a medical oncologist specializing in hematologic malignancies and a clinical investigator. He serves as an Attending Physician in the Adult Leukemia Program at Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. His clinical practice focuses on adult leukemia care, complex hematologic malignancies, and cellular therapy. Dr. Chen’s research explores novel therapeutics for myeloid malignancies, cellular therapy strategies, and leukemia epigenetics. He has co-authored numerous peer-reviewed publications advancing treatment approaches. He is a recipient of the American Society of Hematology HONORS Award. He earned his medical degree from Stanford University School of Medicine, completed his residency in Internal Medicine at Massachusetts General Hospital, and his fellowship in Hematology/Oncology at Dana-Farber Cancer Institute.
Attending Physician
Medical School
2012 – 2016
Residency
2016 – 2019
Fellowship
2019 – 2022